Novartis AG is 19.7x more valuable than Jazz Pharmaceuticals plc by market capitalization ($283.13 B vs $14.41 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | JAZZ | NVS |
|---|---|---|
| Market cap | $14.41 B | $283.13 B |
| US-listed rank | #749 | #47 |
| Revenue (latest FY) | $4.27B | - |
| Net income (latest FY) | -$356.15M | - |
| Net margin | -8.3% | - |
| SEC filings | 2,093 | 947 |
Novartis AG is 19.7x more valuable than Jazz Pharmaceuticals plc by market capitalization ($283.13 B vs $14.41 B).
Full pages: Jazz Pharmaceuticals plc and Novartis AG, or browse the full rankings.